NCI launched TAILORx trial to determine whether gene expression patterns in early-stage breast cancer can distinguish women at high risk of recurrence
| | | | | | |

NCI launched TAILORx trial to determine whether gene expression patterns in early-stage breast cancer can distinguish women at high risk of recurrence

In 2006, the National Cancer Institute (NCI) launched the TAILORx trial to determine whether gene expression patterns in…

Women’s Health Initiative data showed women who take estrogen with hormone progestin have greater risk of developing breast cancer
| | | | | | |

Women’s Health Initiative data showed women who take estrogen with hormone progestin have greater risk of developing breast cancer

In 2004, data from the Women’s Health Initiative (WHI) study show that women who take estrogen in combination…

World’s first use of low-dose radioactive palladium ‘seeds’ was used to treat breast cancer patients at the Women’s Research Institute in Toronto.
| | | | | | |

World’s first use of low-dose radioactive palladium ‘seeds’ was used to treat breast cancer patients at the Women’s Research Institute in Toronto.

In 2004, the world’s first use of low-dose radioactive palladium ‘seeds’ as used to treat breast cancer patients…

NCI clinical trial showed reduced intervals between chemotherapy improved survival in women whose breast cancer had spread to lymph nodes
| | | | | | |

NCI clinical trial showed reduced intervals between chemotherapy improved survival in women whose breast cancer had spread to lymph nodes

On Dec. 12, 2002, the National Cancer Institute (NCI) announced that a clinical trial had shown that reducing…